Abstract:Background The global coronavirus disease 2019 (COVID-19) pandemic seriously affected people's lives. We evaluated anxiety and depression among patients with insomnia in northeast China during the first wave and release of COVID-19, providing a basis for the clinical diagnosis and treatment of insomnia. Methods We enrolled 4211 patients with insomnia from January 2016 to February 2020, August 2020 to February 2022, August 2022 to December 2022, and January 2023 to February 2023, from our institution. Sleep quality was evaluated using the Athens Insomnia Scale, Insomnia Severity Index (ISI), and Pittsburgh sleep quality index (PSQI), while mood disorder and fatigue were evaluated using the Hhospital anxiety and depression scale (HAD), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder (GAD-7), and Fatigue Scale-14 (FS-14). Results Insomnia with depression increased in prevalence after COVID-19 compared with before (12.8¬†% vs. 15.3¬†%, P ¬†<¬†0.05), while the age of patients decreased [(50.2¬†¬Ī¬†15.2) vs. (47.5¬†¬Ī¬†16.8), P ¬†<¬†0.05]. The number of patients with insomnia and severe depression increased compared with before COVID-19 (20.3¬†% vs. 25.3¬†%, P ¬† 2¬†years had depression ( P ¬†<¬†0.05). As the epidemic subsided, insomnia increased among young and male patients (young patients: 55.2¬†% vs. 37.0¬†%; male patients: 41¬†% vs. 27.4¬†%, respectively; P ¬†<¬†0.05). The proportion of patients with insomnia with anxiety and depression increased (53.8¬†% vs. 51.8¬†%, P ¬†<¬†0.05), the proportion with moderate to severe anxiety increased (7.6¬†% vs. 13.5¬†%, P ¬†<¬†0.05), and moderate and severe depression decreased (moderate: 25.6¬†% vs. 19.1¬†%, severe: 25.8¬†% vs. 20.3¬†%, P ¬†<¬†0.05, respectively). Middle-aged and elderly patients had higher PQSI scores in sleep latency, habitual sleep efficiency, subjective sleep quality, and use of sleep medications than young patients ( P ¬†<¬†0.05). The PSQI score was positively correlated with the PHQ-9 score ( r ¬†=¬†0.526), GAD-7 score ( r ¬†=¬†0.563), and FS-14 score ( r ¬†=¬†0.316) ( P ¬†<¬†0.05). Limitations The study was single-center, the sample size was small, and assessment data were lacking from early in the epidemic. The scale is subjective, which may affect the accuracy. Conclusion Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2¬†years had depression. The proportion of patients with insomnia with anxiety and depression was higher after the epidemic period, and the degree worsened. The proportion of insomnia with depression decreased after the epidemic period, and the degree alleviated. The proportion of young male patients with insomnia increased. Middle aged and elderly patients with insomnia had poor sleep quality, which was positively correlated with anxiety, depression, and fatigue.

Supportive psychotherapy on insomnia induced by COVID-19; Evaluation of patients and hospital staff

Digital Cognitive Behavior Therapy for Insomnia Improving Sleep Quality: a Real-World Study

Effect of one-shot cognitive behavioral therapy on insomnia and heart rate variability of health care workers at the time of COVID-19 pandemic: a randomized controlled trial

0318 Early Sleep Intervention Mitigates Poor Sleep and Improves Mood in the COVID-19 Pandemic

Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic

Positive impacts of e-aid cognitive behavioural therapy on the sleep quality and mood of nurses on site during the COVID-19 pandemic

One-Week Self-Guided Internet Cognitive Behavioral Treatments for Insomnia in Adults With Situational Insomnia During the COVID-19 Outbreak

0375 Predictors of Insomnia and Depression in a Randomized Controlled Insomnia Treatment Trial in the COVID-19 Pandemic

Insomnia, Anxiety, and Depression During the COVID-19 Pandemic: an International Collaborative Study

A Prospective Study including Sociodemographic, Occupational and Psychosocial Variables

Decreased Transition Rate From Situational Insomnia to Chronic Insomnia by One-Week Internet Cognitive Behavioral Treatments for Insomnia During the COVID-19 Pandemic

The Impact of COVID-19 on Mental Health and Sleep Function of Hospital Staff Working With COVID-19 Patients: A Cross-Sectional Nationwide Study

The mediating effect of resilience and COVID-19 anxiety on the relationship between social support and insomnia among healthcare workers: a cross-sectional study

An online behavioral self-help intervention rapidly improves acute insomnia severity and subjective mood during the coronavirus disease-2019 pandemic: a stratified randomized controlled trial

Efficacy of Face-to-Face Delivered Cognitive Behavioral Therapy in Improving Health Status of Patients With Insomnia: A Meta-Analysis

The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial

Prevalence of insomnia and its association with quality of life in caregivers of psychiatric inpatients during the COVID-19 pandemic: a network analysis

Association between Sleep Quality and Mental Health among Patients at a Post-COVID-19 Recovery Clinic

Internet delivered, non-inferiority, two-arm, assessor-blinded intervention comparing mindfulness-based stress reduction and cognitive-behavioral treatment for insomnia: a protocol study for a randomized controlled trial for nursing staff with insomnia

0400 Examining the Effectiveness of Telehealth Delivered Cognitive Behavioral Treatment of Insomnia

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey